Search

everythinglearnresearchcommunity

for

Search:↓

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Some common medications can harm male fertility, but many effects can be reversed.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.